Press Releases

All Releases
Apr 09, 2015
AngioDynamics Reports 2015 Third Quarter Financial Results
Third quarter fiscal 2015 net sales of $86.6 million ; flat vs. prior year, excluding the wind down of supply agreement and $1 million on a constant currency basis GAAP loss of $0.12 per share primarily due to one-time non-cash charges Non-GAAP adjusted net income of $0.12 per share, negatively
Mar 26, 2015
AngioDynamics to Report Fiscal 2015 Third Quarter Financial Results
ALBANY, N.Y. , March 26, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 third
Feb 25, 2015
AngioDynamics to Present at the Barclays Global Healthcare Conference
ALBANY, N.Y. , Feb. 25, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph M. DeVivo , President and Chief Executive Officer,
Jan 08, 2015
AngioDynamics Reports 2015 Second Quarter Financial Results
Second Quarter Fiscal 2015 Net Sales increased 4% to $92.1 million ; 5% sales growth excluding supply agreement GAAP EPS of $0.04 ; Non-GAAP adjusted net income of $0.17 per share, a 21% YOY increase EBITDA of $11.9 million ; Adjusted EBITDA of $15.9 million , a 18% YOY increase Company raises
Dec 17, 2014
AngioDynamics to Report Fiscal 2015 Second Quarter Financial Results
ALBANY, N.Y. , Dec. 17, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 second
Dec 09, 2014
AngioDynamics Awarded HealthTrust PICC Contract
ALBANY, N.Y. , Dec. 9, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it signed an agreement with HealthTrust covering PICC
Nov 11, 2014
AngioDynamics to Present at Upcoming Investor Conferences
ALBANY, N.Y. , Nov. 11, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the company will present at the following investor conferences
Oct 13, 2014
AngioDynamics to be Added to the S&P SmallCap 600 Index
ALBANY, N.Y. , Oct. 13, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today it will be added to the S&P SmallCap 600 Index and the GICS Life
Oct 09, 2014
AngioDynamics Reports 2015 First Quarter Financial Results
First Quarter of Fiscal 2015 Net sales increased 4% to $87.3 million ; Sales grew 5%, excluding supply agreement Q1 FY15 GAAP $0.02 ; Non-GAAP adjusted net income of $0.16 per share Q1 FY15 EBITDA of $10.8 million , Adjusted EBITDA of $15.3 million Company provides second quarter guidance and
Sep 25, 2014
AngioDynamics to Report Fiscal 2015 First Quarter Financial Results
ALBANY, N.Y. , Sept. 25, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 first
Displaying 101 - 120 of 642